Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiopathy in systemic sclerosis]

G Valentini1, S Maione

  • 1Cartedra di Reumatologia, Seconda Università, Napoli.

Recenti Progressi in Medicina
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Multimodal Wide-Field Fourier-Transform Raman Microscope.

Journal of visualized experiments : JoVE·2026
Same author

Dataset of night-time emissions of the Earth in the near UV range (290-430 nm), with 6.3 km resolution in the latitude range -51.6<L<+51.6 degrees, acquired on board the International Space Station with the Mini-EUSO detector.

Data in brief·2023
Same author

2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022
Same author

NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022
Same author

Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2021
Same author

Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT<sub>1A</sub> and CB<sub>1</sub> receptors.

Brain research bulletin·2021
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
See all related articles

Systemic sclerosis (SSc) frequently affects the heart. Advanced diagnostics reveal preclinical cardiac disease in many SSc patients, emphasizing the need for regular cardiac screening and tailored treatments.

Area of Science:

  • Cardiology
  • Rheumatology
  • Systemic Sclerosis Research

Context:

  • Cardiac involvement is common in systemic sclerosis (SSc), encompassing primary scleroderma heart disease and secondary conditions.
  • Distinguishing primary SSc heart disease from secondary causes (pulmonary, renal) is crucial for understanding pathophysiology.
  • Autopsy findings reveal a higher prevalence of cardiac involvement than clinical detection, highlighting the need for advanced diagnostics.

Purpose:

  • To differentiate pathophysiologic mechanisms of cardiac involvement in SSc.
  • To explore the diagnostic gap between clinical detection and autopsy findings in SSc patients.
  • To investigate the prognostic significance of cardiac involvement and potential therapeutic interventions.

Summary:

  • Advanced techniques like Holter ECG and echocardiography detect preclinical SSc heart disease in a significant percentage of patients.

Related Experiment Videos

  • Asymptomatic patients may exhibit pericardial effusions, myocardial defects (fixed or reversible), or impaired cardiac reserve.
  • Clinically evident SSc heart disease and ventricular arrhythmias are associated with poor prognosis, necessitating regular cardiological evaluation.
  • Diastolic dysfunction in SSc explains the limited efficacy of inotropic agents, while captopril shows promise in improving cardiac function by addressing vascular disease and fibrosis.

    • Impact:

    • Highlights the importance of comprehensive cardiological work-ups for systemic sclerosis patients.
    • Identifies preclinical SSc heart disease, enabling earlier intervention and improved patient outcomes.
    • Suggests captopril as a potential therapeutic agent for improving cardiac function in SSc by targeting underlying mechanisms.